August 30, 2014 4:40 PM ET

Biotechnology

Company Overview of COR Therapeutics, Inc.

Company Overview

As of February 12, 2002, COR Therapeutics, Inc. was acquired by Millennium Pharmaceuticals Inc. COR Therapeutics, Inc. engages in the discovery, development, and marketing of novel therapeutic products for treating and preventing acute and chronic cardiovascular diseases. It markets INTEGRILIN (eptifibatide) Injection, its approved drug, to treat patients with acute cardiovascular disease. COR has various product development programs underway, each designed to address unmet clinical needs in the management of patients suffering from disorders, such as unstable angina, coronary angioplasty, acute myocardial infarction, stroke, and deep vein thrombosis. The company is based in South San Franci...

256 East Grand Avenue

South San Francisco, CA 94080

United States

Founded in 1988

311 Employees

Phone:

650-244-6800

Key Executives for COR Therapeutics, Inc.

COR Therapeutics, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
VaxInnate, Inc. United States
CuraGen Corporation United States
Vidus Ocular, Inc. United States
Axygen Biosciences, Inc. United States
V-Clip Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COR Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.